Novel antibacterial compounds specifically targeting the essential WalR response regulator

Area of Science:

• Microbiology
• Bacterial Physiology
• Drug Discovery

Background:

• The WalK/WalR two-component system is crucial for Gram-positive bacterial survival.
• This system regulates cell wall metabolism and cell division.
• It is a promising target for new antimicrobial drugs.

Purpose of the Study:

• To develop a high-throughput screening system for WalR inhibitors.
• To identify novel compounds targeting the WalR response regulator.
• To evaluate the antibacterial activity of identified inhibitors.

Main Methods:

• Development of a high-throughput screening assay for WalR inhibitors.
• Identification and characterization of walrycin A and walrycin B.
• Assessment of compound effects on WalR regulon gene expression and bacterial phenotypes.

Main Results:

• Two novel WalR inhibitors, walrycin A and walrycin B, were identified.
• These compounds disrupt WalK/WalR system function, leading to bactericidal effects.
• Observed phenotypes include filamentation in B. subtilis and aggregation in S. aureus.

Conclusions:

• Walrycins A and B are the first identified antibacterial agents targeting the WalR response regulator.
• These compounds demonstrate potential for developing new treatments against B. subtilis and S. aureus infections.